Sickle Cell Disease
-
Webinars
COVID-19 & Haemoglobin Disorders: The Impact of Coronavirus on Sickle Cell Disease Patients
An Expert Panel of Six Medical Professionals from various countries, such as India, the UK, Italy and Saudi Arabia, shared their experiences with TIF on the impact of the COVID-19…
Read More » -
TIF Publications
COVID-19 & Haemoglobin Disorders: Compilation of Information for Sickle Cell Disease (2020)
This document compiles information about the coronavirus pandemic specifically addressed to patients with sickle cell disease (SCD).
Read More » -
Scientific Literature
Sickle Cell Pain Crisis: Clinical Guidelines for the Use of Oxygen
Nocturnal hypoxemia is a prelude to vaso‐occlusive crisis (VOC). Vascular occlusion and disruption of tissue oxygenation are a prequel to excruciating pain, chest splinting with further hypoxemia, acute chest syndrome,…
Read More » -
Scientific Literature
Understanding the Complications of Sickle Cell Disease
Sickle cell disease (SCD) is an autosomal recessive genetic condition that alters the shape and function of the hemoglobin molecule in red blood cells. While the overall survival rate among…
Read More » -
Scientific Literature
The Carrier State for Sickle Cell Disease Is Not Completely Harmless
Sickle cell disease (SCD) is a clinical syndrome caused by the presence of hemoglobin S (HbS), in which glutamic acid in position 6 of the β chain of hemoglobin is…
Read More » -
Scientific Literature
Risk Factors for Mortality in Adult Patients with Sickle Cell Disease: A Meta-analysis of Studies in North America and Europe
Although recent studies show an improved survival of children with sickle cell disease in the US and Europe, for adult patients mortality remains high. This study was conducted to evaluate…
Read More » -
TIF Publications
